Mitochondrial dysfunction in ARDS: unraveling the regulatory networks and therapeutic opportunities.

Li YH, Wang M, Wan K, Li J, Li XF

Open source

DOI
10.3389/fimmu.2026.1899718
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1899718,
  title = {Mitochondrial dysfunction in ARDS: unraveling the regulatory networks and therapeutic opportunities.},
  author = {Li YH and Wang M and Wan K and Li J and Li XF},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1899718},
  url = {https://doi.org/10.3389/fimmu.2026.1899718}
}

RIS

TY  - JOUR
TI  - Mitochondrial dysfunction in ARDS: unraveling the regulatory networks and therapeutic opportunities.
AU  - Li YH
AU  - Wang M
AU  - Wan K
AU  - Li J
AU  - Li XF
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1899718
UR  - https://doi.org/10.3389/fimmu.2026.1899718
ER  - 

APA

YH, L., M, W., K, W., J, L., & XF, L. (2026). Mitochondrial dysfunction in ARDS: unraveling the regulatory networks and therapeutic opportunities.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1899718

Source records